顆粒球マクロファージコロニー刺激因子の世界市場 2020年

• 英文タイトル：Global Granulocyte Macrophage Colony Stimulating Factor Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201111502 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール • 産業分類：医薬品・医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、顆粒球マクロファージコロニー刺激因子の世界市場を調査対象にし、顆粒球マクロファージコロニー刺激因子の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（CG-0070、ギムシルマブ、GSK-3196165、レンジルマブ、MGN-1601、その他）、用途別分析（固形腫瘍、リンパ腫、腎臓がん、肺疾患、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Aduro BioTech Inc、Morphotek Inc、Cold Genesys Inc、Amgen Inc、Mologen AG、BriaCell Therapeutics Corp、Takeda Pharmaceutical Co Ltd、Humanigen Inc、GlaxoSmithKline Plc、Sillajen Biotherapeutics ・メーカー別販売量、売上、市場シェア ・顆粒球マクロファージコロニー刺激因子の地域別市場分析 ・顆粒球マクロファージコロニー刺激因子の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・顆粒球マクロファージコロニー刺激因子のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・顆粒球マクロファージコロニー刺激因子のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・顆粒球マクロファージコロニー刺激因子の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・顆粒球マクロファージコロニー刺激因子の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・顆粒球マクロファージコロニー刺激因子の種類別市場規模2015-2020：CG-0070、ギムシルマブ、GSK-3196165、レンジルマブ、MGN-1601、その他 ・顆粒球マクロファージコロニー刺激因子の用途別市場規模2015-2020：固形腫瘍、リンパ腫、腎臓がん、肺疾患、その他 ・顆粒球マクロファージコロニー刺激因子の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論

Market Overview
The global Granulocyte Macrophage Colony Stimulating Factor market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Granulocyte Macrophage Colony Stimulating Factor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Granulocyte Macrophage Colony Stimulating Factor market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Granulocyte Macrophage Colony Stimulating Factor market has been segmented into
CG-0070
Gimsilumab
GSK-3196165
Lenzilumab
MGN-1601
Others

By Application, Granulocyte Macrophage Colony Stimulating Factor has been segmented into:
Solid Tumor
Lymphoma
Kidney Cancer
Lung Disease
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Granulocyte Macrophage Colony Stimulating Factor market presented in the report. This section sheds light on the sales growth of different regional and country-level Granulocyte Macrophage Colony Stimulating Factor markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Granulocyte Macrophage Colony Stimulating Factor market.

The report offers in-depth assessment of the growth and other aspects of the Granulocyte Macrophage Colony Stimulating Factor market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Granulocyte Macrophage Colony Stimulating Factor Market Share Analysis
Granulocyte Macrophage Colony Stimulating Factor competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Granulocyte Macrophage Colony Stimulating Factor sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Granulocyte Macrophage Colony Stimulating Factor sales, revenue and market share for each player covered in this report.

The major players covered in Granulocyte Macrophage Colony Stimulating Factor are:
Aduro BioTech Inc
Morphotek Inc
Cold Genesys Inc
Amgen Inc
Mologen AG
BriaCell Therapeutics Corp
Takeda Pharmaceutical Co Ltd
Humanigen Inc
GlaxoSmithKline Plc
Sillajen Biotherapeutics

Among other players domestic and global, Granulocyte Macrophage Colony Stimulating Factor market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Granulocyte Macrophage Colony Stimulating Factor product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Granulocyte Macrophage Colony Stimulating Factor, with price, sales, revenue and global market share of Granulocyte Macrophage Colony Stimulating Factor in 2018 and 2019.
Chapter 3, the Granulocyte Macrophage Colony Stimulating Factor competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Granulocyte Macrophage Colony Stimulating Factor breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Granulocyte Macrophage Colony Stimulating Factor market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Granulocyte Macrophage Colony Stimulating Factor sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

Table of Contents

1 Market Overview
1.1 Granulocyte Macrophage Colony Stimulating Factor Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 CG-0070
1.2.3 Gimsilumab
1.2.4 GSK-3196165
1.2.5 Lenzilumab
1.2.6 MGN-1601
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Solid Tumor
1.3.3 Lymphoma
1.3.4 Kidney Cancer
1.3.5 Lung Disease
1.3.6 Others
1.4 Overview of Global Granulocyte Macrophage Colony Stimulating Factor Market
1.4.1 Global Granulocyte Macrophage Colony Stimulating Factor Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Aduro BioTech Inc
2.1.1 Aduro BioTech Inc Details
2.1.2 Aduro BioTech Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Aduro BioTech Inc SWOT Analysis
2.1.4 Aduro BioTech Inc Product and Services
2.1.5 Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Morphotek Inc
2.2.1 Morphotek Inc Details
2.2.2 Morphotek Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Morphotek Inc SWOT Analysis
2.2.4 Morphotek Inc Product and Services
2.2.5 Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Cold Genesys Inc
2.3.1 Cold Genesys Inc Details
2.3.2 Cold Genesys Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Cold Genesys Inc SWOT Analysis
2.3.4 Cold Genesys Inc Product and Services
2.3.5 Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Amgen Inc
2.4.1 Amgen Inc Details
2.4.2 Amgen Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Amgen Inc SWOT Analysis
2.4.4 Amgen Inc Product and Services
2.4.5 Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Mologen AG
2.5.1 Mologen AG Details
2.5.2 Mologen AG Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Mologen AG SWOT Analysis
2.5.4 Mologen AG Product and Services
2.5.5 Mologen AG Granulocyte Macrophage Colony Stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 BriaCell Therapeutics Corp
2.6.1 BriaCell Therapeutics Corp Details
2.6.2 BriaCell Therapeutics Corp Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 BriaCell Therapeutics Corp SWOT Analysis
2.6.4 BriaCell Therapeutics Corp Product and Services
2.6.5 BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Takeda Pharmaceutical Co Ltd
2.7.1 Takeda Pharmaceutical Co Ltd Details
2.7.2 Takeda Pharmaceutical Co Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Takeda Pharmaceutical Co Ltd SWOT Analysis
2.7.4 Takeda Pharmaceutical Co Ltd Product and Services
2.7.5 Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Humanigen Inc
2.8.1 Humanigen Inc Details
2.8.2 Humanigen Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Humanigen Inc SWOT Analysis
2.8.4 Humanigen Inc Product and Services
2.8.5 Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 GlaxoSmithKline Plc
2.9.1 GlaxoSmithKline Plc Details
2.9.2 GlaxoSmithKline Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 GlaxoSmithKline Plc SWOT Analysis
2.9.4 GlaxoSmithKline Plc Product and Services
2.9.5 GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Sillajen Biotherapeutics
2.10.1 Sillajen Biotherapeutics Details
2.10.2 Sillajen Biotherapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Sillajen Biotherapeutics SWOT Analysis
2.10.4 Sillajen Biotherapeutics Product and Services
2.10.5 Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Granulocyte Macrophage Colony Stimulating Factor Manufacturer Market Share in 2019
3.3.2 Top 6 Granulocyte Macrophage Colony Stimulating Factor Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue and Market Share by Regions
4.1.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales and Market Share by Regions (2015-2020)
4.1.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue and Market Share by Regions (2015-2020)
4.2 North America Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2015-2020)
4.3 Europe Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2015-2020)
4.5 South America Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue and Market Share by Country
5.1.1 North America Granulocyte Macrophage Colony Stimulating Factor Sales and Market Share by Country (2015-2020)
5.1.2 North America Granulocyte Macrophage Colony Stimulating Factor Revenue and Market Share by Country (2015-2020)
5.2 United States Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2015-2020)
5.3 Canada Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2015-2020)
5.4 Mexico Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue and Market Share by Country
6.1.1 Europe Granulocyte Macrophage Colony Stimulating Factor Sales and Market Share by Country (2015-2020)
6.1.2 Europe Granulocyte Macrophage Colony Stimulating Factor Revenue and Market Share by Country (2015-2020)
6.2 Germany Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2015-2020)
6.3 UK Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2015-2020)
6.4 France Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2015-2020)
6.5 Russia Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2015-2020)
6.6 Italy Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Revenue and Market Share by Regions (2015-2020)
7.2 China Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2015-2020)
7.3 Japan Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2015-2020)
7.4 Korea Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2015-2020)
7.5 India Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2015-2020)
7.7 Australia Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue and Market Share by Country
8.1.1 South America Granulocyte Macrophage Colony Stimulating Factor Sales and Market Share by Country (2015-2020)
8.1.2 South America Granulocyte Macrophage Colony Stimulating Factor Revenue and Market Share by Country (2015-2020)
8.2 Brazil Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2015-2020)
8.3 Argentina Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2015-2020)
9.3 Turkey Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2015-2020)
9.4 Egypt Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2015-2020)
9.5 South Africa Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales and Market Share by Type (2015-2020)
10.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue and Market Share by Type (2015-2020)
10.3 Global Granulocyte Macrophage Colony Stimulating Factor Price by Type (2015-2020)
11 Global Granulocyte Macrophage Colony Stimulating Factor Market Segment by Application
11.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application (2015-2020)
11.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Application (2015-2020)
11.3 Global Granulocyte Macrophage Colony Stimulating Factor Price by Application (2015-2020)
12 Market Forecast
12.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue and Growth Rate (2021-2025)
12.2 Granulocyte Macrophage Colony Stimulating Factor Market Forecast by Regions (2021-2025)
12.2.1 North America Granulocyte Macrophage Colony Stimulating Factor Market Forecast (2021-2025)
12.2.2 Europe Granulocyte Macrophage Colony Stimulating Factor Market Forecast (2021-2025)
12.2.3 Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Market Forecast (2021-2025)
12.2.4 South America Granulocyte Macrophage Colony Stimulating Factor Market Forecast (2021-2025)
12.2.5 Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Market Forecast (2021-2025)
12.3 Granulocyte Macrophage Colony Stimulating Factor Market Forecast by Type (2021-2025)
12.3.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Type (2021-2025)
12.3.2 Global Granulocyte Macrophage Colony Stimulating Factor Market Share Forecast by Type (2021-2025)
12.4 Granulocyte Macrophage Colony Stimulating Factor Market Forecast by Application (2021-2025)
12.4.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Application (2021-2025)
12.4.2 Global Granulocyte Macrophage Colony Stimulating Factor Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Granulocyte Macrophage Colony Stimulating Factor Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Granulocyte Macrophage Colony Stimulating Factor by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Granulocyte Macrophage Colony Stimulating Factor Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Aduro BioTech Inc Basic Information, Manufacturing Base and Competitors
Table 8. Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Major Business
Table 9. Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Total Revenue (USD Million) (2018-2019)
Table 10. Aduro BioTech Inc SWOT Analysis
Table 11. Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Product and Services
Table 12. Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Morphotek Inc Basic Information, Manufacturing Base and Competitors
Table 14. Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Major Business
Table 15. Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Total Revenue (USD Million) (2018-2019)
Table 16. Morphotek Inc SWOT Analysis
Table 17. Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Product and Services
Table 18. Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Cold Genesys Inc Basic Information, Manufacturing Base and Competitors
Table 20. Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Major Business
Table 21. Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Total Revenue (USD Million) (2018-2019)
Table 22. Cold Genesys Inc SWOT Analysis
Table 23. Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Product and Services
Table 24. Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Amgen Inc Basic Information, Manufacturing Base and Competitors
Table 26. Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Major Business
Table 27. Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Total Revenue (USD Million) (2018-2019)
Table 28. Amgen Inc SWOT Analysis
Table 29. Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Product and Services
Table 30. Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Mologen AG Basic Information, Manufacturing Base and Competitors
Table 32. Mologen AG Granulocyte Macrophage Colony Stimulating Factor Major Business
Table 33. Mologen AG Granulocyte Macrophage Colony Stimulating Factor Total Revenue (USD Million) (2018-2019)
Table 34. Mologen AG SWOT Analysis
Table 35. Mologen AG Granulocyte Macrophage Colony Stimulating Factor Product and Services
Table 36. Mologen AG Granulocyte Macrophage Colony Stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. BriaCell Therapeutics Corp Basic Information, Manufacturing Base and Competitors
Table 38. BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Major Business
Table 39. BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Total Revenue (USD Million) (2018-2019)
Table 40. BriaCell Therapeutics Corp SWOT Analysis
Table 41. BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Product and Services
Table 42. BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Takeda Pharmaceutical Co Ltd Basic Information, Manufacturing Base and Competitors
Table 44. Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Major Business
Table 45. Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Total Revenue (USD Million) (2018-2019)
Table 46. Takeda Pharmaceutical Co Ltd SWOT Analysis
Table 47. Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Product and Services
Table 48. Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Humanigen Inc Basic Information, Manufacturing Base and Competitors
Table 50. Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Major Business
Table 51. Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Total Revenue (USD Million) (2018-2019)
Table 52. Humanigen Inc SWOT Analysis
Table 53. Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Product and Services
Table 54. Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. GlaxoSmithKline Plc Basic Information, Manufacturing Base and Competitors
Table 56. GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Major Business
Table 57. GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Total Revenue (USD Million) (2018-2019)
Table 58. GlaxoSmithKline Plc SWOT Analysis
Table 59. GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Product and Services
Table 60. GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Sillajen Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table 62. Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Major Business
Table 63. Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Total Revenue (USD Million) (2018-2019)
Table 64. Sillajen Biotherapeutics SWOT Analysis
Table 65. Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Product and Services
Table 66. Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Manufacturer (2018-2019) (K Pcs)
Table 68. Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Regions (2015-2020) (K Pcs)
Table 70. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Regions (2015-2020)
Table 71. Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Granulocyte Macrophage Colony Stimulating Factor Sales by Countries (2015-2020) (K Pcs)
Table 73. North America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Countries (2015-2020)
Table 74. North America Granulocyte Macrophage Colony Stimulating Factor Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Countries (2015-2020)
Table 76. Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Countries (2015-2020) (K Pcs)
Table 77. Europe Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Countries (2015-2020)
Table 78. Europe Granulocyte Macrophage Colony Stimulating Factor Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Sales by Regions (2015-2020) (K Pcs)
Table 80. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Granulocyte Macrophage Colony Stimulating Factor Sales by Countries (2015-2020) (K Pcs)
Table 83. South America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Countries (2015-2020)
Table 84. South America Granulocyte Macrophage Colony Stimulating Factor Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Countries (2015-2020) (K Pcs)
Table 87. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Countries (2015-2020)
Table 90. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2015-2020) (K Pcs)
Table 91. Global Granulocyte Macrophage Colony Stimulating Factor Sales Share by Type (2015-2020)
Table 92. Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Type (2015-2020) (USD Million)
Table 93. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Share by Type (2015-2020)
Table 94. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2015-2020) (K Pcs)
Table 95. Global Granulocyte Macrophage Colony Stimulating Factor Sales Share by Application (2015-2020)
Table 96. Global Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Regions (2021-2025) (K Pcs)
Table 97. Global Granulocyte Macrophage Colony Stimulating Factor Market Share Forecast by Regions (2021-2025)
Table 98. Global Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Type (2021-2025) (K Pcs)
Table 99. Global Granulocyte Macrophage Colony Stimulating Factor Market Share Forecast by Type (2021-2025)
Table 100. Global Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Application (2021-2025)
Table 101. Global Granulocyte Macrophage Colony Stimulating Factor Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Granulocyte Macrophage Colony Stimulating Factor Picture
Figure 2. Global Sales Market Share of Granulocyte Macrophage Colony Stimulating Factor by Type in 2019
Figure 3. CG-0070 Picture
Figure 4. Gimsilumab Picture
Figure 5. GSK-3196165 Picture
Figure 6. Lenzilumab Picture
Figure 7. MGN-1601 Picture
Figure 8. Others Picture
Figure 9. Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application in 2018
Figure 10. Solid Tumor Picture
Figure 11. Lymphoma Picture
Figure 12. Kidney Cancer Picture
Figure 13. Lung Disease Picture
Figure 14. Others Picture
Figure 15. Global Granulocyte Macrophage Colony Stimulating Factor Market Status and Outlook (2015-2025) (USD Million)
Figure 16. United States Granulocyte Macrophage Colony Stimulating Factor Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Canada Granulocyte Macrophage Colony Stimulating Factor Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Mexico Granulocyte Macrophage Colony Stimulating Factor Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Germany Granulocyte Macrophage Colony Stimulating Factor Revenue (Value) and Growth Rate (2015-2025)
Figure 20. France Granulocyte Macrophage Colony Stimulating Factor Revenue (Value) and Growth Rate (2015-2025)
Figure 21. UK Granulocyte Macrophage Colony Stimulating Factor Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Russia Granulocyte Macrophage Colony Stimulating Factor Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Italy Granulocyte Macrophage Colony Stimulating Factor Revenue (Value) and Growth Rate (2015-2025)
Figure 24. China Granulocyte Macrophage Colony Stimulating Factor Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Japan Granulocyte Macrophage Colony Stimulating Factor Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Korea Granulocyte Macrophage Colony Stimulating Factor Revenue (Value) and Growth Rate (2015-2025)
Figure 27. India Granulocyte Macrophage Colony Stimulating Factor Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Southeast Asia Granulocyte Macrophage Colony Stimulating Factor Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Australia Granulocyte Macrophage Colony Stimulating Factor Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 30. Brazil Granulocyte Macrophage Colony Stimulating Factor Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Egypt Granulocyte Macrophage Colony Stimulating Factor Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Saudi Arabia Granulocyte Macrophage Colony Stimulating Factor Revenue (Value) and Growth Rate (2015-2025)
Figure 33. South Africa Granulocyte Macrophage Colony Stimulating Factor Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Turkey Granulocyte Macrophage Colony Stimulating Factor Revenue (Value) and Growth Rate (2015-2025)
Figure 35. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Manufacturer in 2019
Figure 36. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Manufacturer in 2019
Figure 37. Top 3 Granulocyte Macrophage Colony Stimulating Factor Manufacturer (Revenue) Market Share in 2019
Figure 38. Top 6 Granulocyte Macrophage Colony Stimulating Factor Manufacturer (Revenue) Market Share in 2019
Figure 39. Key Manufacturer Market Share Trend
Figure 40. Global Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 41. Global Granulocyte Macrophage Colony Stimulating Factor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 42. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Regions (2015-2020)
Figure 43. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Regions in 2018
Figure 44. North America Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2015-2020)
Figure 45. Europe Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2015-2020)
Figure 46. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2015-2020)
Figure 47. South America Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2015-2020)
Figure 48. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2015-2020)
Figure 49. North America Granulocyte Macrophage Colony Stimulating Factor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 50. North America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Countries (2015-2020)
Figure 51. North America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Countries in 2018
Figure 52. North America Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 53. North America Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Countries in 2018
Figure 54. United States Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 55. Canada Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 56. Mexico Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 57. Europe Granulocyte Macrophage Colony Stimulating Factor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 58. Europe Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Countries (2015-2020)
Figure 59. Europe Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Countries in 2019
Figure 60. Germany Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. UK Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. France Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 63. Russia Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 64. Italy Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 65. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 66. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Regions 2019
Figure 67. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Regions 2019
Figure 68. China Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Japan Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. Korea Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 71. India Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 72. Southeast Asia Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 73. South America Granulocyte Macrophage Colony Stimulating Factor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. South America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Countries in 2019
Figure 75. South America Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Countries in 2019
Figure 76. Brazil Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 77. Argentina Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 78. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 79. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Countries in 2019
Figure 80. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Countries (2015-2020)
Figure 81. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Countries in 2019
Figure 82. Saudi Arabia Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Egypt Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 84. Turkey Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 85. South Africa Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 86. Global Granulocyte Macrophage Colony Stimulating Factor Sales and Growth Rate (2021-2025) (K Pcs)
Figure 87. Global Granulocyte Macrophage Colony Stimulating Factor Revenue and Growth Rate (2021-2025) (USD Million)
Figure 88. North America Sales Granulocyte Macrophage Colony Stimulating Factor Market Forecast (2021-2025) (K Pcs)
Figure 89. Europe Sales Granulocyte Macrophage Colony Stimulating Factor Market Forecast (2021-2025) (K Pcs)
Figure 90. Asia-Pacific Sales Granulocyte Macrophage Colony Stimulating Factor Market Forecast (2021-2025) (K Pcs)
Figure 91. South America Sales Granulocyte Macrophage Colony Stimulating Factor Market Forecast (2021-2025) (K Pcs)
Figure 92. Middle East & Africa Sales Granulocyte Macrophage Colony Stimulating Factor Market Forecast (2021-2025) (K Pcs)
Figure 93. Sales Channel: Direct Channel vs Indirect Channel

---